glp 1 ra GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential Glucagon-like peptide-1 receptor: mechanisms and
Description
Retatrutide is an investigational compound not approved for any therapeutic use
Pregnancy and breastfeeding : GLP-1 receptor agonists are not recommended during pregnancy
In January 2025, Novo Nordisk disclosed key findings from the STEP UP study , a Phase IIIb trial within the global STEP program
GLP-1 drugs are a class of medications that mimic the incretin hormone GLP-1 to aid in blood sugar control and appetite regulation
Heart rate and blood pressure assessment Blood pressure and electrocardiogram (ECG) were recorded in anaesthetized, lean mice
Combined R&D spend of over $300 billion in 2024 (27% of sales) could fall to 21% of sales in 2030, Evaluate projects
